Thousands of women took Sanofi epilepsy drug despite risk to fetuses-media

PARIS, Aug 9 (Reuters) - More than 10,000 pregnant women in

France took Sanofi's anti-epilepsy drug Depakine between 2007

and 2014 although the risk of fetus malformation was known,

according to a study quoted by French satirical weekly Le Canard

Enchaine.

Read more